课题基金 / 基金详情

A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH

A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH
一项 3 期、双盲、多中心、随机、安慰剂对照试验
批准号:
7606043
负责人:
Carlos Milla
金额:
$3.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

Carlos Milla的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究旨在评估氨曲南赖氨酸盐雾化吸入(AI,Cayston)28天的安全性和有效性,以及在28天的妥布霉素雾化溶液(TSI,TOBI)治疗后,AI维持或改善临床状况的能力。这项研究的主要目的是评估吸入性或静脉注射抗菌素所需的时间。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is designed to assess the safety and efficacy of a 28-day treatment with Aztreonam Lysinate for Inhalation (AI, Cayston) and the ability of AI to maintain or improve clinical status following a 28-day course of Tobramycin Solution for Inhalation (TSI, TOBI) therapy in cystic fibrosis (CF) patients with pulmonary Pseudomonas aeruginosa (PA). The primary endpoint of this study is to evaluate the time to need for inhaled or IV antibotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis lung Infections
  • 批准号:
    10463594
  • 项目类别:
  • 资助金额:
    $41.95万
  • 财政年份:
    2019
  • 负责人:
    Carlos Milla
  • 依托单位:
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis lung Infections
  • 批准号:
    9803696
  • 项目类别:
  • 资助金额:
    $42.02万
  • 财政年份:
    2019
  • 负责人:
    Carlos Milla
  • 依托单位:
INHALED SODIUM PYRUVATE FOR THE TREATMENT OF CYSTIC FIBROSIS A PHASE I, DOUBLE
  • 批准号:
    7606079
  • 项目类别:
  • 资助金额:
    $0.94万
  • 财政年份:
    2006
  • 负责人:
    Carlos Milla
  • 依托单位:
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF DENUFOSOL TETRAS
  • 批准号:
    7606078
  • 项目类别:
  • 资助金额:
    $0.94万
  • 财政年份:
    2006
  • 负责人:
    Carlos Milla
  • 依托单位:
海外基金